{"schema_version":"1","generated_at":"2026-10-30T10:31:48.973Z","data_as_of":"2026-10-27","url":"https://www.findmykol.com/kol/jie-wang","json_url":"https://www.findmykol.com/kol/jie-wang/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"jie-wang","name":"Jie Wang","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Lung","therapeutic_areas":["Lung","Gastrointestinal"],"city":"Philadelphia","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1215257183"},"summary":"Jie Wang is a Lung Cancer (NSCLC/SCLC) physician. ClinicalTrials.gov lists 55 registered studies with this person as an investigator.","overview":{"text":"Jie Wang, MD, is profiled from the public federal record. It also documents an investigator role on 55 registered clinical trials, industry payments reported by 12 companies.","bullets":["Top research focus: Lung Cancer (NSCLC/SCLC)","55 registered trials on ClinicalTrials.gov","Open Payments reporting from 12 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":24,"topics":0,"strength":72},{"label":"Small Cell Lung Carcinoma","therapeutic_area":"Oncology","trials":18,"topics":0,"strength":54},{"label":"Coronary Artery Disease / ACS","therapeutic_area":"Cardiology","trials":5,"topics":0,"strength":15},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Rectal Neoplasms","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"HIV","therapeutic_area":"Infectious Disease","trials":3,"topics":0,"strength":9},{"label":"HIV Infections","therapeutic_area":"Infectious Disease","trials":3,"topics":0,"strength":9},{"label":"Acquired Immunodeficiency Syndrome","therapeutic_area":"Infectious Disease","trials":3,"topics":0,"strength":9},{"label":"Coronary Artery Disease","therapeutic_area":"Cardiology","trials":2,"topics":0,"strength":6},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Stomach Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Helicobacter Infections","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"ESRD / Dialysis","therapeutic_area":"Nephrology","trials":1,"topics":0,"strength":3},{"label":"Glomerular Disease","therapeutic_area":"Nephrology","trials":1,"topics":0,"strength":3},{"label":"Coronary Stenosis","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Constriction, Pathologic","therapeutic_area":"Epidemiology","trials":1,"topics":0,"strength":3},{"label":"Depression (MDD)","therapeutic_area":"Psychiatry","trials":1,"topics":0,"strength":3},{"label":"Pain","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Chronic Pain","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Stress Disorders, Post-Traumatic","therapeutic_area":"Psychiatry","trials":1,"topics":0,"strength":3},{"label":"Parkinson's Disease","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Huntington Disease","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Alzheimer's / Dementia","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Cognitive Dysfunction","therapeutic_area":"Psychiatry","trials":1,"topics":0,"strength":3},{"label":"Chronic Kidney Disease","therapeutic_area":"Nephrology","trials":1,"topics":0,"strength":3},{"label":"Neoplasm Metastasis","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Carcinoma, Squamous Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Esophageal Squamous Cell Carcinoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Pleural Effusion","therapeutic_area":"Respiratory","trials":1,"topics":0,"strength":3},{"label":"Pleural Effusion, Malignant","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoproliferative Disorders","therapeutic_area":"Hematology","trials":1,"topics":0,"strength":3},{"label":"Carcinoma, Pancreatic Ductal","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Carcinoma, Ductal","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, T-Cell, Peripheral","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Lymphoma, T-Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Carcinoma, Small Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Adenocarcinoma of Lung","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Malnutrition","therapeutic_area":"Endocrinology/Metabolic","trials":1,"topics":0,"strength":3},{"label":"Angina, Stable","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3},{"label":"Angina, Unstable","therapeutic_area":"Cardiology","trials":1,"topics":0,"strength":3}],"research_topics":["Lung Cancer (NSCLC/SCLC)","Small Cell Lung Carcinoma","Colorectal Cancer","Rectal Neoplasms","Adenocarcinoma of Lung","Brain Neoplasms","Gastroesophageal Cancer","Head & Neck Cancer","Neoplasm Metastasis","Pleural Effusion, Malignant","Stomach Neoplasms"],"drugs_studied":{"total":9,"shown":3,"withheld":6,"rows":[{"name":"Beleodaq","generic":"Belinostat","trials":0,"payments":15,"publications":0,"mentions":15},{"name":"Poteligeo","generic":"Mogamulizumab","trials":0,"payments":3,"publications":0,"mentions":3},{"name":"Adcetris","generic":"Brentuximab vedotin","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":30,"shown":3,"withheld":27,"rows":[{"name":"Acrotech Biopharma Inc.","trials":0,"payments":14,"mentions":14},{"name":"Guang'anmen Hospital of China Academy of Chinese Medical Sciences","trials":8,"payments":0,"mentions":8},{"name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","trials":7,"payments":0,"mentions":7}]}},"scholarship":{"h_index":0,"pubmed_count":0,"latest_activity_year":2025,"source":"works"},"trials":{"count":55,"shown":3,"withheld":52,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07668037","title":"Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy","status":"RECRUITING","role":"Investigator","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","source_url":"https://clinicaltrials.gov/study/NCT07668037","trial_url":"https://www.findmykol.com/trial/NCT07668037"},{"nct":"NCT07649369","title":"A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion","phase":"PHASE2","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"Shanghai Jeyou Pharmaceutical Co., Ltd.","source_url":"https://clinicaltrials.gov/study/NCT07649369","trial_url":"https://www.findmykol.com/trial/NCT07649369"},{"nct":"NCT07459751","title":"A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer","phase":"PHASE2/PHASE3","status":"RECRUITING","role":"Investigator","sponsor":"Shanghai Henlius Biotech","source_url":"https://clinicaltrials.gov/study/NCT07459751","trial_url":"https://www.findmykol.com/trial/NCT07459751"}],"source":"trials"},"payments":{"company_count":12,"program_years":{"first":2022,"last":2025},"rows_total":15,"shown":3,"withheld":12,"rows":[{"payer":"Acrotech Biopharma Inc.","program_year":2025,"amount_usd":3779.69,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215257183"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2025,"amount_usd":135,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215257183"},{"payer":"KYOWA KIRIN, INC.","program_year":2025,"amount_usd":121.34,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215257183"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1215257183","source":"payments"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":43.5,"classes_total":2,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":28.6,"drugs":[{"name":"Brukinsa","share_pct":50},{"name":"Imbruvica","share_pct":50}],"max_beneficiaries":null},{"class":"Folate Analog Metabolic Inhibitor","setting":"prescribed","share_pct":14.9,"drugs":[{"name":"Methotrexate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":28,"classes_total":2,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":19,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":16},{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":8.9,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":13}]},{"area":"Dermatology","share_pct":12.5,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":12.5,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":13}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":65.6,"facility_pct":34.4},"source":"medicare"},"funding":{"award_count":0,"rows_total":3,"shown":3,"withheld":0,"rows":[{"project":"R43CA134047","title":"Intraperitoneal Tumor-Targeting Chemo-gene Therapy","fiscal_year":2009,"amount_usd":125561,"organization":"OPTIMUM THERAPEUTICS, LLC","source_url":"https://reporter.nih.gov/quickSearch/R43CA134047"},{"project":"R43CA134047","title":"Intraperitoneal Tumor-Targeting Chemo-gene Therapy","fiscal_year":2008,"amount_usd":122613,"organization":"OPTIMUM THERAPEUTICS, LLC","source_url":"https://reporter.nih.gov/quickSearch/R43CA134047"},{"project":"R43CA121744","title":"rTS Signaling Mimetics As Novel Cancer Therapeutics","fiscal_year":2006,"amount_usd":163657,"organization":"OPTIMUM THERAPEUTICS, LLC","source_url":"https://reporter.nih.gov/quickSearch/R43CA121744"}],"source":"grants"},"publications":{"total":0,"shown":0,"withheld":0,"recent":[],"source":"works"},"similar":[{"name":"Pasi Janne","slug":"pasi-janne","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/pasi-janne","json_url":"https://www.findmykol.com/kol/pasi-janne/profile.json"},{"name":"Julie Brahmer","slug":"julie-brahmer","institution":"Johns Hopkins University School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/julie-brahmer","json_url":"https://www.findmykol.com/kol/julie-brahmer/profile.json"},{"name":"Enriqueta Felip","slug":"enriqueta-felip","institution":"Vall d'Hebron Institute of Oncology (VHIO)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/enriqueta-felip","json_url":"https://www.findmykol.com/kol/enriqueta-felip/profile.json"},{"name":"Funda Meric-Bernstam","slug":"funda-meric-bernstam","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Surgery","url":"https://www.findmykol.com/kol/funda-meric-bernstam","json_url":"https://www.findmykol.com/kol/funda-meric-bernstam/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":52,"payments":12}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-28"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2022 to 2025","collected_at":"2026-10-28"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}